Similarly, BMPR1A mutations, implicated in TGF-beta signaling, were significantly enriched in the EOCRC H/L patients (5.1% vs. 1.8%, p < 0.05), reinforcing prior findings that alterations in this pathway may contribute to CRC progression in H/L individuals [5]. Here, BMPR1A is linked to colorectal carcinoma.